Lumakras (sotorasib) will soon be made available in England on the National Health Service for eligible lung cancer patients, following an early access agreement reached with the drug’s manufacturer, Amgen.
NHS England, Amgen and health technology assessment body NICE reached the deal to enable early access to the first-in-class, KRAS...







